The Company will hold a conference call at 8:00 am ET on November 11, 2010 to discuss third quarter 2010 results. Listeners may access the call by dialing 1-800-659-2056 or 1-617-614-2714 for international callers, access code: 56441223. A webcast will also be available through CPHI's website at http://www.chinapharmaholdings.com. A replay of the call will be accessible through November 18, 2010 by dialing 1-888-286-8010 or 1-617-801-6888 for international callers, access code: 99472174.
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. is a specialty pharmaceutical company with rapidly growing profit that develops, manufactures, and markets treatments for a wide range of high incidence and high mortality conditions in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company's cost-effective, high margin business model is driven by market demand and supported by eight scalable GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding distribution network across 30 provinces, municipalities and autonomous regions. The Company is registered in Delaware, USA. Hainan Helpson Medical & Biotechnology Co., Ltd. (Helpson), located in Haikou City, Hainan Province, China, is a wholly owned subsidiary of China Pharma Holdings, Inc. For more information about China Pharma Holdings, Inc., please visit http://www.chinapharmaholdings.com.
Contact: | ||
China Pharma Holdings, Inc. | CCG Investor Relations | |
Phone: +86-898-6681-1730 (China) | Kalle Ahl, Account Manager | |
Email: hps@chinapharmaholdings.com | Phone: +1-646-833-3417 (New York) | |
Email: kalle.ahl@ccgir.com | ||
Vivian Chen, Sr. Market Intelligence Exec. | ||
Phone: +1-(646)-701-7445(New York) | ||
Email: vivian.chen@ccgir.com | ||
SOURCE China Pharma Holdings, Inc.
